Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Fiorucci

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Recent Advances in Inflammation & Allergy Drug Discovery|March 7, 2022
Development of Effective and Safe Analgesic and Anti-Inflammatory Drugs: Harnessing Natural Substances for Clinical SolutionsStefano Fiorucci
Inflammation & Allergy Drug Targets|February 1, 2011
Hydrogen sulfide: from physiology to pharmacologyStefano Fiorucci
Recent Advances in Inflammation & Allergy Drug Discovery|August 18, 2022
Rescuing inflammation By Inflammasome InhibitorsStefano Fiorucci
Gastroenterology Clinics of North America|May 19, 2009
Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the futureStefano Fiorucci
Current Topics in Medicinal Chemistry|January 17, 2012
Current advances in therapeutic applications of nuclear receptorsStefano Fiorucci
Inflammation & Allergy Drug Targets|February 1, 2011
An update in H(2)S in physiology, pathophysiology and pharmacologyStefano Fiorucci
Liver Research|February 17, 2025
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver diseaseMichele Biagioli, Stefano Fiorucci
Current Opinion in Pharmacology|June 17, 2006
PPARs and other nuclear receptors in inflammationGiovanni Rizzo, Stefano Fiorucci
Journal of Cellular and Molecular Medicine|January 1, 2010
FXR an emerging therapeutic target for the treatment of atherosclerosisAndrea Mencarelli, Stefano Fiorucci
Pharmacological Research|August 1, 2016
Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertensionStefano Fiorucci, Eleonora Distrutti
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Recent Advances in Inflammation & Allergy Drug Discovery|March 7, 2022
Development of Effective and Safe Analgesic and Anti-Inflammatory Drugs: Harnessing Natural Substances for Clinical SolutionsStefano Fiorucci
Inflammation & Allergy Drug Targets|February 1, 2011
Hydrogen sulfide: from physiology to pharmacologyStefano Fiorucci
Recent Advances in Inflammation & Allergy Drug Discovery|August 18, 2022
Rescuing inflammation By Inflammasome InhibitorsStefano Fiorucci
Gastroenterology Clinics of North America|May 19, 2009
Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the futureStefano Fiorucci
Current Topics in Medicinal Chemistry|January 17, 2012
Current advances in therapeutic applications of nuclear receptorsStefano Fiorucci
Inflammation & Allergy Drug Targets|February 1, 2011
An update in H(2)S in physiology, pathophysiology and pharmacologyStefano Fiorucci
Liver Research|February 17, 2025
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver diseaseMichele Biagioli, Stefano Fiorucci
Current Opinion in Pharmacology|June 17, 2006
PPARs and other nuclear receptors in inflammationGiovanni Rizzo, Stefano Fiorucci
Journal of Cellular and Molecular Medicine|January 1, 2010
FXR an emerging therapeutic target for the treatment of atherosclerosisAndrea Mencarelli, Stefano Fiorucci
Pharmacological Research|August 1, 2016
Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertensionStefano Fiorucci, Eleonora Distrutti
Pageof 29